DUBLIN, Calif., Nov. 13 /PRNewswire-FirstCall/ -- SuperGen, Inc. (Nasdaq: SUPG), a pharmaceutical company dedicated to the discovery and development of novel cancer therapies, today announced that James S. Manuso, Ph.D., President and Chief Executive Officer is scheduled to present at the Lazard Capital Markets Fifth Annual Healthcare Conference on Tuesday, November 18, 2008 at the St. Regis in New York, New York.
SuperGen's presentation at the Lazard Capital Markets Fifth Annual Healthcare Conference is scheduled to begin at 4:40 p.m. EDT (1:40 p.m. PDT). A live webcast of the presentation will be available on the investor relations section of the Company's Web site at http://www.supergen.com. The webcast will be archived for 90 days.
Based in Dublin, Calif., SuperGen, Inc. is a pharmaceutical company
dedicated to the discovery and development of novel cancer therapies.
SuperGen is developing a number of therapeutic anticancer products focused
on kinase and cell signaling inhibitors and DNA methyltransferase
inhibitors. For more information about SuperGen, please visit
SuperGen, Inc. Dorland Global Public Relations
Timothy L. Enns Michael Beckerich (Media)
SVP, Corporate Communications Tel: (212) 677-7632
& Business Development firstname.lastname@example.org
Tel: (925) 560-2810
|SOURCE SuperGen, Inc.|
Copyright©2008 PR Newswire.
All rights reserved